Nephros Financials

Earnings View

Profitability View

Liquidity View

Fundamentals View

Competition View

Nephros Stock Summary

Nephros competes with Precision Optics,, Repro Med, InfuSystems Holdings, Utah Medical, and Milestone Scientific. Nephros, Inc. develops and sells high performance water solutions to the medical and commercial markets in the United States. The company was incorporated in 1997 and is headquartered in South Orange, New Jersey. Nephros operates under Medical Instruments Supplies classification in the United States and is traded on NASDAQ Exchange. It employs 34 people.

Nephros Key Financial Ratios

Nephros Key Balance Sheet Accounts

Nephros Key Income Statement Accounts

Nephros Key Cash Accounts

Nephros Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Nephros's current stock value. Our valuation model uses many indicators to compare Nephros value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Nephros competition to find correlations between indicators driving Nephros's intrinsic value. More Info.Nephros is considered to be number one stock in return on equity category among its peers. It also is considered to be number one stock in return on asset category among its peers . As of now, Nephros' Return On Equity is decreasing as compared to previous years. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Nephros' earnings, one of the primary drivers of an investment's value.

Nephros Systematic Risk

Today, most investors in Nephros Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Nephros' growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Nephros growth as a starting point in their analysis.

Along with financial statement analysis, the daily predictive indicators of Nephros help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Nephros. We use our internally-developed statistical techniques to arrive at the intrinsic value of Nephros based on widely used predictive technical indicators. In general, we focus on analyzing Nephros Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Nephros's daily price indicators and compare them against related drivers.

When running Nephros' price analysis, check to measure Nephros' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nephros is operating at the current time. Most of Nephros' value examination focuses on studying past and present price action to predict the probability of Nephros' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nephros' price. Additionally, you may evaluate how the addition of Nephros to your portfolios can decrease your overall portfolio volatility.